Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹107.77
  • Day's High
  • ₹114.45
₹ 112.02
  • 52-w low
  • ₹77.35
  • 52-w high
  • ₹149.6
112.02
  • Day's open
    ₹109.4
  • Previous close
    ₹108.980003
  • VWAP
    ₹111.01
  • Lower price band
    ₹87.18
  • Upper price band
    ₹130.77

Today's Market Action

The last traded share price of Bliss GVS Pharma Ltd was 112.02 up by 2.79% on the NSE. Its last traded stock price on BSE was 112.50 up by 3.31%. The total volume of shares on NSE and BSE combined was 815,438 shares. Its total combined turnover was Rs 9.05 crores.

Medium and Long Term Market Action

Bliss GVS Pharma Ltd hit a 52-week high of 149.6 on 28-11-2023 and a 52-week low of 77.35 on 26-10-2023. The stock price of Bliss GVS Pharma Ltd is up by 8% over the last one month. It is up by 15.96% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 1143

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Bliss GVS Pharma Ltd?

What is the Market Cap of Bliss GVS Pharma Ltd?

What is PE Ratio of Bliss GVS Pharma Ltd?

What is PB Ratio of Bliss GVS Pharma Ltd?

What is the CAGR of Bliss GVS Pharma Ltd?

How to Buy Bliss GVS Pharma Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 101.33% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 252 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(23/07/2024)
Stock Valuation
Green line
102
50.00%
50.00% People are bullish about Bliss GVS Pharma Ltd
50.00%
50.00 % People are bearish about Bliss GVS Pharma Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Bliss GVS Pharma Ltd

112.02 +3.04 (2.79%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %